-
Interviews with leading Life Sciences companies: Pixie Dust Technologies
Pixie Dust Technologies invented a new audio method with gamma wave sound to prevent or … Read more
-
Venture Valuation/Biotechgate Announces Participation in Biotech Showcase, the J.P. Morgan 41st Annual Healthcare Conference 2024 and RESI
ZURICH, Switzerland, December 2023 – Venture Valuation/Biotechgate (the “Company”) is delighted to announce its participation … Read more
-
Venture Valuation Strengthens its Presence in North America With Sales Team Expansion
Zurich, Switzerland, December 2023 – Venture Valuation announces that it has appointed Bill Colihan and … Read more
-
Interviews with leading Life Sciences companies: Rebirthel
Rebirthel are preparing the first clinical trial conducted in humans for acute myeloid leukemia to … Read more
-
Life Sciences M&A Report: Half-Year 2023
In the first half of 2023, the slowdown in terms of global life sciences M&A … Read more
-
ライフサイエンス 企業: 欧州事業拠点の 立地選定
ライフ サイエンス事業を立ち上げたり拡大したりする際に、適切な場所を選択するのは簡単なことではありません。 Venture Valuation との協力により KPMG が作成したこのレポートでは、欧州における事業拠点選定プロセスの概要と、各国の包括的分析内容を提供いたします。
-
Site Selection for Life Sciences Companies in Europe
Choosing the right location when setting up or expanding your life science operations is no … Read more
-
Interviews with leading Life Sciences companies: Human Life Cord
Human Life Cord specialize in allogeneic cell therapy, applying umbilical cord derived mesenchymal stromal cells … Read more
-
Venture Valuation/Biotechgate and One Nucleus Partner to Boost Life Sciences Connectivity and Innovation
Zurich, Switzerland and Cambridge, UK, September 2023 – Biotechgate, a leading global life sciences business … Read more
-
A Formula for Drug Licensing Deals
Venture Valuation’s Elias Neuendorf, Kara E. O’Connell, Patrik Frei and Kumlesh Kumar Dev recently had … Read more